The latest news: Curtana Pharmaceuticals Successfully Completes Pre-IND Submission for CT-179 for the Treatment of Malignant Gliomas This sounds exciting - it is a new target which is not usually found on normal brain but is found in GBM cells - especially cancer stem cells BrainTumor Co-Payment Assistance Program Status: OPEN to new applicants
